NDC 42292-040
Levothyroxine Sodium 175 ug tablet
On the label: Mylan Institutional Inc.. It's repackaged from NDC 0378-1817, made by Mylan Pharmaceuticals Inc. (Levothyroxine Sodium). That product's FDA listing has since ended, so its label and factories are no longer published.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Mylan Institutional Inc. names for other drugs.
Recalls
- Nov 19, 2024 · Class II · Mylan Institutional, Inc.
Subpotent and Superpotent Drug
Lots: Lot #: 3115707, Exp. Date 02/2025 - Nov 19, 2024 · Class II · Mylan Institutional, Inc.
Subpotent and Superpotent Drug
Lots: Lot #: 3115448, Exp. Date 12/31/2024;3115732, Exp. Date 3/31/2025; 3116024, Exp. Date 9/30/2025 - Nov 19, 2024 · Class II · Mylan Institutional, Inc.
Subpotent and Superpotent Drug
Lots: Lot #: 3115869, Exp. Date 03/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet, oral
- Strength
- 175 ug
- Approval
- ANDA ANDA076187
- On the market since
- Jan 19, 2017
- Package NDCs
42292-040-0142292-040-20- Official label
- DailyMed (National Library of Medicine), updated Jul 23, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?